- Home
- CLGN vs KZR Comparison
CLGN vs KZR Comparison
Compare CLGN & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- KZR
- Stock Information
- Founded
- CLGN 2004
- KZR 2015
- Country
- CLGN Israel
- KZR United States
- Employees
- CLGN N/A
- KZR N/A
- Industry
- CLGN Industrial Specialties
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- CLGN Health Care
- KZR Health Care
- Exchange
- CLGN Nasdaq
- KZR Nasdaq
- Market Cap
- CLGN 51.3M
- KZR 54.1M
- IPO Year
- CLGN N/A
- KZR 2018
- Fundamental
- Price
- CLGN $3.77
- KZR $6.29
- Analyst Decision
- CLGN Strong Buy
- KZR Hold
- Analyst Count
- CLGN 2
- KZR 2
- Target Price
- CLGN $12.50
- KZR $11.00
- AVG Volume (30 Days)
- CLGN 13.5K
- KZR 58.2K
- Earning Date
- CLGN 11-27-2024
- KZR 11-12-2024
- Dividend Yield
- CLGN N/A
- KZR N/A
- EPS Growth
- CLGN N/A
- KZR N/A
- EPS
- CLGN N/A
- KZR N/A
- Revenue
- CLGN $650,000.00
- KZR N/A
- Revenue This Year
- CLGN N/A
- KZR N/A
- Revenue Next Year
- CLGN $692.59
- KZR N/A
- P/E Ratio
- CLGN N/A
- KZR N/A
- Revenue Growth
- CLGN N/A
- KZR N/A
- 52 Week Low
- CLGN $3.31
- KZR $5.20
- 52 Week High
- CLGN $6.99
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- CLGN 34.26
- KZR 25.06
- Support Level
- CLGN $3.60
- KZR $6.80
- Resistance Level
- CLGN $4.17
- KZR $7.04
- Average True Range (ATR)
- CLGN 0.19
- KZR 0.26
- MACD
- CLGN -0.05
- KZR -0.07
- Stochastic Oscillator
- CLGN 2.26
- KZR 3.68
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.